
QuinXell Technologies Pte Ltd was founded in 2011 as a member of Quintech Life Sciences (QLS) group of companies established to tap on the life sciences global industry. The company creates innovative cell culture-based products and services for the advancement of scientific research with clinical impact.
Through the QLS group, QuinXell has a worldwide distribution network covering sales and marketing, as well as application and service support to its customers. The organization’s vibrant collaborative culture with the scientific and medical community uniquely defines QuinXell spirit to bring about “A Renaissance in Regenerative Medicine”.
Quinxell’s novel TisXell Regeneration System offers a favourable environment for high growth and high proliferation of cell cultures compared to conventional methods.
The biaxial bioreactor controlled environment provides optimal nutrients and gases to growing cells and triggers cellular mechano-transduction signalling pathways to stimulate tissue remodelling onto a three dimensional (3D) scaffold.
Our integrated solution comprising TisXell Regeneration System and scaffolds addresses tissue engineering applications with unsurpassed performance especially for slow growing cells like bone cells, stem cells and primary cells.




